Founded in Paris in 1920, Gide is a leading international law firm with 12 offices spread throughout the world.
Gide is physically present in six regions of the world, with 11 offices, enabling it to act on cases globally.
17 December 2020
Deals | France | US | International Capital Markets
Gide has advised the underwriters, Jefferies LLC, Evercore Group LLC, UBS Securities LLC and Gilbert Dupont, on the initial public offering of Nanobiotix on the Nasdaq Global Market, consisting in a public offer of 8,395,000 ordinary shares, mainly in the form of American Depositary Shares (ADSs), for an estimated total gross amount of USD 113.3 million, after full exercise of the over-allotment clause.
Nanobiotix is a late-stage French developer of nanoparticle drugs that improve cancer radiotherapy. Established in 2003, the company has been listed on Euronext since 2012.
Gide advised the underwriters on French law aspects, with a team headed by partner Arnaud Duhamel and counsel Guilhem Richard, working with associates Juliette Pierre and Mélanie Simon. The tax aspects were handled by counsel Alexandre Bochu. The underwriters were advised by Cooley LLP on US law aspects.
Nanobiotix was represented by Jones Day on aspects of US and French law.
